India to Canada: Calcium Export Trade Route
India has recorded 491 verified shipments of Calcium exported to Canada, representing a combined trade value of $271.3M USD. This corridor is served by 34 active Indian exporters, with an average shipment value of $552.6K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 93% of total export value with 27 shipments worth $251.5M USD. On the buying side, BIOMEDPHARMA is the largest importer in Canada with $193.7M USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, MEDREICH LIMITED — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Canada Calcium corridor is one of India's established pharmaceutical export routes, with 491 shipments documented worth a combined $271.3M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 93% of all export value, reflecting the consolidated nature of India's calcium manufacturing sector.
Across 34 active suppliers, the average shipment value stands at $552.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 33.6%, placing it at rank #10 among India's top calcium export destinations globally.
On the import side, key buyers of Indian calcium in Canada include BIOMEDPHARMA, ACCORD HEALTHCARE INC.,, SUN PHARMA CANADA INC. and 66 others. BIOMEDPHARMA is the single largest importer with 4 shipments valued at $193.7M USD.
Route Characteristics
- Average transit27 days
